Delivery Order SPE2DB20D3103-SPE2DB23FM2T0
Award Date
1/26/23
Potential Completion Date
1/27/23
Potential Value
$5.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,260.97 Firm Fixed Price Delivery Order is for the supply of Thrombin-JMI 20,000 units vials, a critical medical product. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., which serves as the primary vehicle for the...
This federal contract award, valued at $5,928.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the delivery of 20,000 unit vials of Thrombin-JMI, a medical product. It is a firm fixed-price delivery order contract with an ultimate completion date of April 1, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,739.44 firm fixed-price delivery order is for the supply of 20,000 unit vials of Thrombin-JMI, a specialized blood coagulant product. This order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 through November 2026. The...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order (SPE2DB20D3103) with a Ceiling Value of $9,633.40. The contract is for the supply of THROMBIN-JMI 20,000 UNIT VIALS to the Defense Logistics Agency (DLA), a defense agency. The contract is a Firm Fixed Price arrangement with an Ultimate Completion Date of October 28, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award, valued at $4,801.44, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 20,000 unit vials of Thrombin-JMI, a specialized medical product, with a period of performance through January 27, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical, which...
This federal contract award to Amerisourcebergen Drug Corp (Amerisourcebergen) is a delivery order valued at $18,754.65 for the supply of 20,000 unit vials of THROMBIN-JMI, a specialty pharmaceutical product. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal...
This federal contract award, with ID SPE2DB22D2007|SPE2DB24FJ1BQ, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The $2,346.50 firm fixed price delivery order is for the supply of 20,000 unit vials of the pharmaceutical product Thrombin-JMI. The contract has an ultimate completion date of April 2, 2024. AmerisourceBergen Drug Corp, acting as the prime contractor, will...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,970.50 firm fixed-price delivery order contract is for the supply of 20,000 unit vials of the medication RECOTHROM. The contract has an ultimate completion date of January 31, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,566.81 firm-fixed price delivery order is for the supply of 20,000 unit vials of the medication RECOTHROM. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a leading pharmaceutical sourcing and distribution company. The $4,885.48 firm fixed price delivery order is for the supply of 20,000 unit vials of the specialty medication RECOTHROM. This award is part of a larger indefinite delivery contract (IDC) between AmerisourceBergen Drug Corp and DLA, valued up to $999,999,999.00, for the provision of pharmaceutical products and medical...